Dr. Rakibul Islam is a clinical epidemiologist interested in non-communicable diseases in women and is currently working at the Women's Health Research Program at Monash University, Australia. His current projects address sex hormones and their impact on cardiovascular disease risk as well as on cancer, cognition, and frailty in older Australian women, which has attractive possibilities for pharmacological interventions aimed at prolonging the morbidity-free life span of older women. He is a lead researcher in a large study of young Australian women's physical and psychological health. He also works on projects on African and Middle Eastern refugees in Australia and Rohingya refugees in Bangladesh.

Dr. Islam is a highly experienced women's health epidemiologist with over 80 publications in reputed journals, including the Lancet, the Lancet Diab & Endo, BMJ, JAMA, and JCEM. Dr. Islam was an invited speaker in the full-day workshop in Berlin, Germany, to develop the first “global consensus position statement on the use of testosterone therapy for women.” His role was to ensure all the leading clinicians from 11 international societies understood the major meta-analysis that he undertook.  Hence, he was awarded the Australasian Menopause Society Scientific Prize in 2020, which is highly prestigious.

He earned his PhD from the School of Public Health and Preventive Medicine, Monash University, Australia. He completed his first year of post-doctoral fellowship at the Baker Heart and Diabetes Institute, Australia, in collaboration with CDC, USA. Dr. Islam has over 10 years of teaching experience in Bangladesh and Australia. He currently teaches introductory epidemiology and introductory biostatistics for BioMed Honours students at Monash University, Australia. 

Research Profile: ResearchGate GoogleScholar